G19S (p.Gly19Ser) variant of NLGN3 (Neuroligin-3)
G19S (p.Gly19Ser) in NLGN3 (Neuroligin-3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
G19S (p.Gly19Ser) variant details
- p.Gly19Ser
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available